Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 162

Results For "ITU"

1812 News Found

Sun Pharma's Winlevi available in the US
Drug Approval | November 01, 2021

Sun Pharma's Winlevi available in the US

It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years


Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22
News | October 29, 2021

Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22

Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021


Rainbow hospital gives new lease of life to infant on ECMO support
Healthcare | October 28, 2021

Rainbow hospital gives new lease of life to infant on ECMO support

The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease


Oasis Fertility forays into Karnataka plans 10 more centres
Hospitals | October 28, 2021

Oasis Fertility forays into Karnataka plans 10 more centres

It plans to double its network to 50 centres across India in the next three years


Thermo Fisher Scientific unveils Q Digital PCR system
Medical Device | October 28, 2021

Thermo Fisher Scientific unveils Q Digital PCR system

It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development


Novavax files for approval of its Covid-19 vaccine in the UK
Biotech | October 27, 2021

Novavax files for approval of its Covid-19 vaccine in the UK

Filing marks first protein-based vaccine submitted to MHRA for authorization


PM launches PM Ayushman Bharat Health Infrastructure Mission
Public Health | October 26, 2021

PM launches PM Ayushman Bharat Health Infrastructure Mission

Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country


Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22
News | October 25, 2021

Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22

The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively


Biocon Q2FY22 in line with estimates, better margins: ICICI Direct
News | October 25, 2021

Biocon Q2FY22 in line with estimates, better margins: ICICI Direct

Key takeaways of recent quarter & conference call highlights


Novartis cancer drug trial does not meet primary end points
Biotech | October 25, 2021

Novartis cancer drug trial does not meet primary end points

The company is continuing with the evaluation of canakinumab in lung cancer, and is applying findings to the overall lung cancer development plan